Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | TP53 | P04637 | 1/20 | 0.52 |
| ▸ | TSHR | P16473 | 1/20 | 0.52 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.48 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.48 |
| ▸ | FNTA | P49354 | 1/20 | 0.47 |
| ▸ | FNTB | P49356 | 1/20 | 0.47 |
| ▸ | SRD5A2 | P31213 | 1/20 | 0.46 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.46 |
| ▸ | RAB9A | P51151 | 2/20 | 0.46 |
| ▸ | NPC1 | O15118 | 1/20 | 0.46 |
| ▸ | HPGD | P15428 | 1/20 | 0.46 |
| ▸ | AGTR1 | P30556 | 1/20 | 0.46 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.46 |
| ▸ | AKR1C3 | P42330 | 1/20 | 0.44 |
| ▸ | POLB | P06746 | 1/20 | 0.44 |
| ▸ | CA12 | O43570 | 1/20 | 0.44 |
| ▸ | CA1 | P00915 | 1/20 | 0.44 |
| ▸ | CA2 | P00918 | 1/20 | 0.44 |
| ▸ | CA3 | P07451 | 1/20 | 0.44 |
| ▸ | TYR | P14679 | 1/20 | 0.44 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Methane SCHEMBL364406 | 0.98 | TP53 (0.50) | TP53TSHRKDM4ETDP1FNTA | |
| SCHEMBL5692310 | 0.89 | ALDH1A1 (0.44) | ALDH1A1RAB9ANPC1HPGDAGTR1 | |
| SCHEMBL29051542 | 0.87 | ALDH1A1 (0.46) | KDM4EALDH1A1RAB9ANPC1HPGD | |
| SCHEMBL25719356 | 0.84 | TSHR (0.55) | TP53TSHRKDM4ETDP1FNTA | |
| SCHEMBL8639589 | 0.83 | L3MBTL1 (0.46) | TSHRKDM4ETDP1ALDH1A1RAB9A | |
| SCHEMBL31555876 | 0.83 | FNTA (0.49) | TP53TSHRKDM4ETDP1FNTA | |
| SCHEMBL8637256 | 0.83 | MAPT (0.52) | ALDH1A1RAB9ANPC1HPGDAGTR1 | |
| SCHEMBL12666032 | 0.83 | TDP1 (0.49) | TP53TSHRKDM4ETDP1FNTA | |
| SCHEMBL20882094 | 0.82 | TSHR (0.57) | TP53TSHRFNTAFNTBSRD5A2 | |
| SCHEMBL9621441 | 0.80 | KDM4E (0.47) | TP53TSHRKDM4ETDP1FNTA |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 440 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11938106-B2 | Treatment of tinnitus using glutamate receptor agonists | NORTHEAST OHIO MEDICAL UNIVERSITY (US) | 2024-03-26 | — | — | US | claimed |
| US-20230038631-A1 | TREATMENT OF TINNITUS USING GLUTAMATE RECEPTOR AGONISTS | NORTHEAST OHIO MEDICAL UNIV (US) | 2023-02-09 | — | — | US | claimed |
| WO-2022122668-A1 | COMBINED INHIBITION OF AMINO ACID TRANSPORTERS FOR INHIBITING HUMAN PLASMACYTOID DENDRITIC CELL ACTIVITY DURING AUTOIMMUNITY | MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-06-16 | — | — | WO | claimed |
| EP-4008330-A1 | COMBINED INHIBITION OF AMINO ACID TRANSPORTERS FOR INHIBITING HUMAN PLASMACYTOID DENDRITIC CELL ACTIVITY DURING AUTOIMMUNITY | Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. (DE) | 2022-06-08 | — | — | EP | claimed |
| US-11304917-B2 | Treatment of tinnitus using glutamate receptor agonists | NORTHEAST OHIO MEDICAL UNIVERSITY (US) | 2022-04-19 | — | — | US | claimed |
| US-20210251928-A1 | TREATMENT OF TINNITUS USING GLUTAMATE RECEPTOR AGONISTS | NORTHEAST OHIO MEDICAL UNIVERSITY | 2021-08-19 | — | — | US | claimed |
| EP-3302493-B1 | INHIBITORS OF CYSTINE-GLUTAMATE TRANSPORTER FOR USE IN TREATING OR PREVENTING SUBSTANCE-RELATED AND ADDICTIVE DISORDERS | UNIV CHINA MEDICAL (TW) | 2021-07-07 | — | — | EP | claimed |
| US-20210177869-A1 | METHODS AND COMBINATIONS FOR MODULATING TOLERANCE TO OPIATES, OPIOIDS OR OPIOID ANALGESICS AND TREATING ACUTE AND CHRONIC PAIN | CHINA MEDICAL UNIVERSITY (TW) | 2021-06-17 | — | — | US | claimed |
| CN-107735094-B | New use of inhibitors of cystine-glutamate transporter | 中国医药大学 | 2021-05-28 | — | — | CN | claimed |
| CN-112839679-A | Methods and combinations for modulating tolerance to opiates, opioids or opioid analgesics and treating acute and chronic pain | 中国医药大学 | 2021-05-25 | — | — | CN | claimed |
| EP-1773306-A1 | MEDICAMENT FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | Greenpharma (FR) | 2007-04-18 | — | — | EP | claimed |
| WO-2006018538-A1 | MEDICAMENT FOR THE TREATMENT OF CENTRAL NERVOUS SYSTEM DISORDERS | GREENPHARMA (FR) | 2006-02-23 | — | — | WO | claimed |
| US-6197820-B1 | METABOTROPIC GLUTAMATE RECEPTOR AGONIST/ANTAGONIST (S)-4-CARBOXYPHENYLGLYCINE (S-4CPG), POTENTLY AND SELECTIVELY INHIBITED GLUTAMATE RELEASE FROM GLIOMA CELLS AND THEREBY PREVENTED NEUROTOXICITY, INHIBIT RELEASE OF TOXIC LEVELS OF | UAB RESEARCH FOUNDATION | 2001-03-06 | — | — | US | claimed |
| WO-2000062771-A1 | USES OF PHENYLGLYCINE DERIVATIVES | THE UAB RESEARCH FOUNDATION (US) | 2000-10-26 | — | — | WO | claimed |
| EP-1038023-A1 | AGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS AND USES THEREOF | THE UAB RESEARCH FOUNDATION (US) | 2000-09-27 | — | — | EP | claimed |
| US-6013672-A | ADMINISTERING TO AN INDIVIDUAL SUFFERING FROM HEAD, SPINAL CORD TRAUMA, STROKE AND EPILEPSY A THERAPEUTICALLY EFFECTIVE DOSE OF A METABOTROPIC GLUTAMATE RECEPTOR AGONIST | UAB RESEARCH FOUNDATION (US) | 2000-01-11 | — | — | US | claimed |
| WO-1999031268-A1 | AGONISTS OF METABOTROPIC GLUTAMATE RECEPTORS AND USES THEREOF | UAB RESEARCH FOUNDATION (US) | 1999-06-24 | — | — | WO | claimed |
| US-5587509-A | Caged caboxyl compounds and use thereof | CORNELL RESEARCH FOUNDATION, INC. (US) | 1996-12-24 | — | — | US | claimed |
| US-5430175-A | Caged carboxyl compounds and use thereof | CORNELL RESEARCH FOUNDATION, INC. (US) | 1995-07-04 | — | — | US | claimed |
| WO-1995015305-A1 | CAGED CARVOXYL COMPOUNDS AND THEIR USE IN CHEMICAL KINETIC INVESTIGATION OF NEUROTRANSMITTER RECEPTORS | CORNELL RESEARCH FOUNDATION, INC. (US) | 1995-06-08 | — | — | WO | claimed |